Morgan Stanley Initiates Coverage on Yangnong Chemical: Positioning for Cycle Reversal at Valuation Trough

Overview

Morgan Stanley initiates coverage of Yangnong Chemical (600486.SS) with an Overweight rating and a CNY 71 target price. The report argues that although short-term pressures exist from declining farmer planting economics and high raw material costs, company valuations are already at a 10-year trough with limited downside risk. With the potential for the Middle East conflict to trigger an agricultural price upcycle and global pesticide channel inventories normalizing, the industry is expected to enter a phase of restocking and profit recovery over the next three years, suggesting an accumulation strategy at the current cycle bottom.

Core views

The bullish logic is based on three dimensions. First, valuation safety margin: the company's forward P/E is currently below 15x and P/B is below 2x, both in the bottom tier of the past decade, reflecting pessimistic market expectations for short-term fundamentals but leaving limited room for decline. Second, macro catalysts: the Middle East conflict has caused global fertilizer and fuel prices to surge. Historically, such supply shocks often precede upcycles in the pesticide sector, as expectations of higher grain prices stimulate farmer inputs and channel stocking. Third, inventory cycle positioning: after two years of destocking, channel inventories of major global pesticide companies have returned to healthy levels, laying the foundation for the next round of restocking. Addressing recent market concerns, the report acknowledges that declining farmer purchasing power and rising raw material prices are short-term headwinds. Due to significant increases in input costs like fertilizer and diesel, pesticide demand for the South Hemisphere's 2026-27 planting season may be restrained, and rising upstream raw material costs (e.g., sulfur, yellow phosphorus) could compress profit margins in the second half of the year. However, the report judges these pressures to be largely temporary; as agricultural prices transmit through the value chain in 2027-28 and raw material costs normalize, the company's profitability is expected to undergo more substantial recovery. At the company level, Yangnong Chemical, as a leading global producer of generic pesticides, derives nearly 60% of its revenue from overseas and its performance is highly correlated with the global pesticide cycle. While there are no new large-scale projects under construction, the capacity ramp-up at the Liaoning Youchuang base continues, with expected double-digit growth in active ingredient sales in 2026. Combined with a moderate rebound in average product prices in 2026 and a potential volume-price surge in 2028, the report forecasts net profit growth of 23%, 3%, and 45% for 2026-28 respectively, with the strong rebound in 2028 serving as the key driver for revaluation.

Analysis framework

The report adopts a typical 'Cycle Bottom + Catalyst' analytical framework. First, it establishes the current safety margin by vertically comparing historical valuations (10-year percentiles for P/E and P/B), excluding the risk of chasing highs. Second, it utilizes cross-asset correlation analysis to map the historical transmission chain of 'Crude Oil/Fertilizer Prices → Agricultural Prices → Pesticide Demand', arguing how the Middle East conflict acts as an exogenous variable triggering a new upcycle. Third, by tracking financial conference call transcripts from the world's top four pesticide giants (Corteva, Bayer, BASF, FMC), it cross-validates the industry fact that channel inventories have shifted from 'destocking' to 'normalization'. Finally, at the company level, it employs a volume-price decomposition model to distinguish between endogenous growth driven by capacity ramp-up and cyclical elasticity driven by market recovery, leading to the conclusion of accelerated earnings growth in 2028.

Methodology notes

• Valuation MethodologyPE/PEG valuation

  Mid-cycle valuation anchor for cyclicals

  For strongly cyclical industries, using only the current low P/E can fall into a 'valuation trap.' The report selects the midpoint of a mid-cycle P/E range of 15-20x (18x) as the target valuation multiple, rather than current trough or peak multiples, aiming to reflect reasonable pricing after earnings normalization and avoid being misled by cyclical extremes.

• Cycle and Prosperity FrameworkInventory cycle (Kitchin)

  Channel inventory normalization as a leading indicator for restocking

  The report tracks downstream channel inventory levels to determine cycle position. When channel inventories destock from high levels to 'healthy/normal' levels, it signifies the end of passive destocking; once terminal demand shows marginal improvement, it will trigger an active restocking cycle, which is a key signal for judging the turning point of pesticide sector prosperity.

• Industry/Industrial Analysis FrameworkUpstream-Midstream-Downstream Transmission

  Leading indicator role of agricultural prices on pesticide demand

  Pesticide demand is not an independent variable but lags behind agricultural prices. The report points out that historically, crop price increases often precede pesticide upcycles, as higher grain prices improve farmers' planting return expectations, thereby increasing their willingness to pay and procurement volume for agricultural inputs. This transmission mechanism is the core logic for predicting industry recovery.

• Company Fundamentals and Financial FrameworkVolume-price decomposition

  Distinguishing endogenous growth from cyclical elasticity

  When forecasting earnings for cyclical stocks, revenue drivers are decomposed into 'volume' and 'average price'. Volume growth mainly comes from new capacity rollout (e.g., Liaoning base ramp-up), representing company-specific Alpha; meanwhile, price changes depend on industry supply/demand and cost pass-through, representing Beta. This decomposition helps identify which growth is certain and which requires cyclical tailwinds.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Yangnong Chemical (600486.SS)

  Core Beneficiary: As a leading global generic pesticide producer with a high overseas revenue share, it directly benefits from the global pesticide restocking cycle and the rise in agricultural prices.

  Strengths

  Valuation at a 10-year bottom; vertical integration provides cost advantages; Liaoning base capacity ramp-up provides endogenous incremental growth; customer base covers global major pesticide giants.

  Weaknesses

  Short-term constraints from declining farmer purchasing power and high raw material costs; lack of new large-scale construction projects, long-term sales growth depends on increased utilization of existing capacity.

  Comparison

  P/E slightly higher than commodity chemical stocks, but lower than the A-share special chemicals sector average; P/B is in line with commodity chemical stocks.

  Risks

  Long-term disruption in fertilizer and fuel supplies further suppressing farmer income; domestic new capacity delays price recovery; regulatory and litigation risks.

Key data

• Target PriceCNY 71.00Based on 18x 2026 expected P/E, positioned at the midpoint of the mid-cycle valuation range
• Current ValuationP/E <15x, P/B <2.0xBoth near 10-year historical lows
• Net Profit Growth Forecast 2026-28+23%, +3%, +45%Substantial profit rebound expected in 2028
• Overseas Revenue ShareApprox. 57%-58%2025 data, indicating high sensitivity of the company to the global pesticide cycle
• Active Ingredient Sales Growth 2026+10%Mainly driven by capacity ramp-up at the Liaoning Youchuang base
• Bull Case Target PriceCNY 99.00Corresponds to 20x 2026 P/E, assuming entry into the upcycle earlier from late 2026 to early 2027
• Bear Case Target PriceCNY 39.00Corresponds to 12x 2026 P/E, assuming fundamental recovery fails

Impact & implications

The report suggests that Yangnong Chemical's current investment value lies in 'finding a certain bottom amidst uncertainty.' For investors focusing on cycle reversal, the current position offers a high payoff ratio: even if fundamentals fluctuate in the short term, valuations have fully priced in pessimistic expectations; however, should the Middle East situation persist or agricultural prices confirm an upturn, the company will benefit from the dual elasticity of both earnings upgrades and valuation expansion. Additionally, domestic pesticide industry policies are trending towards promoting consolidation and high-quality development. Coupled with slowed capital expenditure among leading enterprises, the medium-term supply-demand structure is expected to optimize, benefiting leading enterprises with cost and scale advantages to emerge from the trough first.

Risks

• If fertilizer and fuel production supply remains disrupted for a prolonged period, it will further squeeze farmers' planting returns, leading to a decline in sowing area and pesticide demand in the medium term.
• Continuous expansion of domestic pesticide capacity may suppress product prices, delaying the restocking rhythm and the speed of profit recovery.
• Some pesticide products face increasingly stringent regulatory reviews and potential litigation risks (e.g., Glyphosate, Paraquat), which may impact financial performance and stock prices.

What to watch

• Evolution of the Middle East conflict and its subsequent impact on global fertilizer, fuel, and agricultural prices
• Actual progress of global pesticide channel inventory digestion and the timing of restocking orders
• Farmer input willingness and actual changes in sowing area during the South Hemisphere's 2026-27 planting season
• Progress in improving capacity utilization at the company's Liaoning Youchuang base and the ramp-up schedule for new products
• Implementation of domestic pesticide industry consolidation policies and the exit of small and medium capacity.